Entrar Registro gratuito

Last updated: 18 June 2019 at 5:07am EST

Kent J Davies Net Worth




The estimated Net Worth of Kent J Davies is at least $1.25 Milhão dollars as of 23 October 2015. Kent Davies owns over 278 units of Haemonetics stock worth over $1,223,753 and over the last 10 years Kent sold HAE stock worth over $28,634.

Kent Davies HAE stock SEC Form 4 insiders trading

Kent has made over 3 trades of the Haemonetics stock since 2015, according to the Form 4 filled with the SEC. Most recently Kent sold 278 units of HAE stock worth $8,827 on 23 October 2015.

The largest trade Kent's ever made was selling 279 units of Haemonetics stock on 23 July 2015 worth over $10,981. On average, Kent trades about 139 units every 15 days since 2014. As of 23 October 2015 Kent still owns at least 16,891 units of Haemonetics stock.

You can see the complete history of Kent Davies stock trades at the bottom of the page.



What's Kent Davies's mailing address?

Kent's mailing address filed with the SEC is 400 WOOD ROAD, , BRAINTREE, MA, 02184.

Insiders trading at Haemonetics

Over the last 21 years, insiders at Haemonetics have traded over $82,114,016 worth of Haemonetics stock and bought 334,931 units worth $14,646,550 . The most active insiders traders include Paul Black, Robert E Abernathy, eBrad Nutter. On average, Haemonetics executives and independent directors trade stock every 13 days with the average trade being worth of $539,753. The most recent stock trade was executed by Stewart W Strong on 26 July 2024, trading 4,312 units of HAE stock currently worth $393,039.



What does Haemonetics do?

haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right



What does Haemonetics's logo look like?

Haemonetics Corp. logo

Complete history of Kent Davies stock trades at Haemonetics

Data
#
Companhia
 Acionista maioritário
Trans.
Transação
 Ações Preço por ação Preço total Ações após Fonte
23 Oct 2015 HAE Haemonetics Corp. Kent J Davies
Presidente e Global Markets
 Venda 278 $31.75 $8,827
23 Oct 2015
16,891 ↗
23 Oct 2015 HAE Haemonetics Corp. Kent J Davies
Presidente e Global Markets
 Venda 278 $31.75 $8,827
23 Oct 2015
16,891 ↗
23 Jul 2015 HAE Haemonetics Corp. Kent J Davies
Presidente e Global Markets
 Venda 279 $39.36 $10,981
23 Jul 2015
6,540 ↗


Haemonetics executives and stock owners

Haemonetics executives and other stock owners filed with the SEC include: